Main Street Health has closed a $315 million round of funding. The company’s pre-money valuation for the round was $1.2 billion, according to a company spokesperson. That means Main Street has entered “unicorn” territory, a buzzy Silicon Valley term for startups with a ten-digit-plus valuation. Here's why that's notable and what's next for the firm:
